Short Interest in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Decreases By 66.6%

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the recipient of a significant drop in short interest in July. As of July 15th, there was short interest totaling 756 shares, a drop of 66.6% from the June 30th total of 2,265 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 11,543 shares, the short-interest ratio is presently 0.1 days.

Hedge Funds Weigh In On Fidelity Disruptive Medicine ETF

Large investors have recently added to or reduced their stakes in the company. Glass Jacobson Investment Advisors llc raised its stake in shares of Fidelity Disruptive Medicine ETF by 44.0% in the 4th quarter. Glass Jacobson Investment Advisors llc now owns 1,260 shares of the company’s stock valued at $34,000 after purchasing an additional 385 shares during the period. Virtu Financial LLC acquired a new position in shares of Fidelity Disruptive Medicine ETF during the fourth quarter worth about $228,000. Vise Technologies Inc. bought a new stake in Fidelity Disruptive Medicine ETF in the 4th quarter valued at approximately $234,000. BXM Wealth LLC acquired a new position in Fidelity Disruptive Medicine ETF during the 4th quarter worth approximately $243,000. Finally, Jane Street Group LLC boosted its position in Fidelity Disruptive Medicine ETF by 0.8% during the 1st quarter. Jane Street Group LLC now owns 66,382 shares of the company’s stock worth $1,567,000 after acquiring an additional 499 shares during the last quarter.

Fidelity Disruptive Medicine ETF Stock Performance

Fidelity Disruptive Medicine ETF stock opened at $28.34 on Friday. Fidelity Disruptive Medicine ETF has a 1 year low of $22.80 and a 1 year high of $30.33. The firm’s 50 day moving average price is $26.83 and its two-hundred day moving average price is $26.09. The firm has a market cap of $45.34 million, a price-to-earnings ratio of 41.33 and a beta of 0.74.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.